Budget impact analysis of a new prostate cancer risk index for prostate cancer detection. - Wikidata - wikimedia - TriplyDB

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

http://www.wikidata.org/entity/Q46098777

about

Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer Emerging PSA-based tests to improve screening Budget impact model: epigenetic assay can help avoid unnecessary repeated prostate biopsies and reduce healthcare spending.Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1.Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer.Commercialized biomarkers: new horizons in prostate cancer diagnostics.Cost-effectiveness of Prostate Health Index for prostate cancer detection.The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA i Does the Prostate Health Index Depend on Tumor Volume?-A Study on 196 Patients after Radical Prostatectomy.Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting.

P2860

Q26781089-26736B56-5928-4B4A-88FE-FBB9973A882B Q26824913-6E0AF594-89DC-4F2C-995B-96850B0D1955 Q26828563-E1AD174F-2162-4914-9133-695E9E715717 Q33652793-0D0F3976-8CBB-4156-BF30-FBF8FD669200 Q33668692-11450626-D406-4D06-9CDE-123F62CAE235 Q33911725-95E08BB9-2FB3-4C4D-89E6-608C69838D9B Q38023597-2568425C-1B43-4DA6-8D5B-40D10D2C9D49 Q38364797-3E78BCB0-7071-4577-8A31-BEB741924B3B Q40007049-55FBA04E-0A0E-459A-B76D-A8ED4AA81D47 Q40267154-A2075385-8DDF-4BFE-B6EC-329BDF85E070 Q41837254-05E9C514-25AD-483B-BF2E-F29DC7F8D38B Q51781558-40C415B3-FB44-42AA-B5E8-4280441FD4B8

P2860

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

http://www.wikidata.org/entity/Q46098777

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

@en

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

@nl

type

label

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

@en

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

@nl

prefLabel

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

@en

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

@nl

P1433

Q46098777-5EC3713A-E77B-4B8E-AA3E-42B36257B472

P1476

Q46098777-BC416780-31E1-41B5-B1E9-D2C2A6348355

P2093

Q46098777-11C42D01-AF94-4C7E-8BC5-D225148F67F9

Q46098777-71C7FE37-4063-4F34-B343-CBA3EA967C52

Q46098777-D7D4A386-88A5-4F9A-9B28-65E34650D389

Q46098777-ED6CE651-45FF-47A7-AA11-95F7CDFE0272

Q46098777-F107DDF6-55B5-4A94-B30B-314F108A39DE

P2860

Q46098777-053FB6E2-2A09-45A3-8370-B4DA84B99A1F

Q46098777-06C34117-A8C5-4D75-820B-A30FCF261784

Q46098777-0867B29C-A559-48A0-89FB-251BDFD89EC3

Q46098777-0953B86E-687D-49A3-8CAF-30C0FDE6A051

Q46098777-0D2F8E06-5E9E-44FC-94E3-0E7D19A3B222

Q46098777-271C647A-E139-43D0-9A5E-9E4675DB9653

Q46098777-29112AF3-2EF8-4DA2-9F0C-39552A972E68

Q46098777-435BBB5D-BE42-451B-B224-BFACAA15D362

Q46098777-49F44DE5-E7A4-47A4-9C82-28347B56C4E1

Q46098777-4BE0B7AB-C6E0-4D0E-A327-1104870A97D7

P2888

Q46098777-CE80675F-0F22-4762-9620-0CA752FB257B

P304

Q46098777-65558551-616F-4B85-97FF-0AF094E45094

P31

Q46098777-702B0A34-19EC-42D5-A464-D9BFEDDF4970

P356

Q46098777-CA8E571C-ED03-4C42-A5B2-355FF129418E

P433

Q46098777-DF264789-B877-4F78-9644-352D617FF05B

P478

Q46098777-E0016DE6-5B4A-4282-B188-0E3020834AD7

P50

Q46098777-0C9E3D63-BC48-4638-80FF-E508BE0E714C

Q46098777-FC930259-7510-43D1-9AFD-57995C300075

P577

Q46098777-20D112C8-70BC-482B-AB3F-9F00AAA78F6B

P5875

Q46098777-2F9CC77B-8E47-4CA4-B063-F9E8F6ECECD7

P698

Q46098777-4CF8F1FA-CB7A-4AE7-907F-D63FA4929D56

P356

P1433

Prostate Cancer and Prostatic Diseases

P1476

Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.

@en

P2093

D Denham

http://www.w3.org/2001/XMLSchema#string

J Huang

http://www.w3.org/2001/XMLSchema#string

J J An

http://www.w3.org/2001/XMLSchema#string

J Wu

http://www.w3.org/2001/XMLSchema#string

S Frencher

http://www.w3.org/2001/XMLSchema#string

P2860

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey

American Cancer Society guideline for the early detection of prostate cancer: update 2010

Cancer statistics, 2009

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.

Prostate-specific antigen: current status.

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

Prostate specific antigen best practice statement: 2009 update.

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.

Prostate-specific antigen in the early detection of prostate cancer.

P2888

P304

253-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/PCAN.2011.16

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Steven J Jacobsen

Michael B. Nichol

P577

2011-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51093328

http://www.w3.org/2001/XMLSchema#string

P698

21537346

http://www.w3.org/2001/XMLSchema#string